Anika Therapeutics Appoints Constance Garrison as VP of Regulatory and Clinical Affairs
13th Nov 2006, 17:22 GMT
Seasoned Executive Brings More Than 20 Years Experience to Company
Anika Therapeutics Appoints Constance Garrison as VP of Regulatory and Clinical Affairs related news:
- Tacere Therapeutics Appoints VP, R&D — Pharmaceuticals News from StratCenter.com
- Tacere Therapeutics Appoints Vice President, Research and Development — RedOrbit News - Health
- MoD is considering an Army 'super-garrison' — Telegraph News | UK News
- Garrison International Ltd.: Garrison Enters Into a Purchase Agreement with Asia Intercept Mining Group Limited — Market Wire - Manufacturing and Production
- Kendle Appoints Sylva H Collins, PhD, as VP, Global Biometrics — Information Technologies/ MIS/ HIS News from StratCenter.com
- Corcept Therapeutics Completes Enrollment In Third Phase 3 Study For Treating Psychotic Major Depression — Health News from Medical News Today
- Garrison Enters Into a Purchase Agreement with Asia Intercept Mining Group Limited — ArriveNet : Press Releases
- Repros Therapeutics 3Q Loss Widens — Financial News News from StratCenter.com
- CHAD Therapeutics revenue down, loss up in 2Q — Latest news from Los Angeles Business from bizjournals
- CBS picks program VP — Variety.com
Latest news from Executive Announcements News from StratCenter.com:
- Accuro Healthcare Solutions Announces New CTO
- Streamline Health named to Forbes Magazine's List of The 200 Best Small Companies for 2006
- Southern Research CEO Jack Secrist Recognized for Contributions in Cancer Drug Research
- Zuckerman named treasurer for CHW
- MQ Assoc Announces Results for Q3 of 2006 and 9 Months Ended 9/30/2006
- KB Home CEO Leaves After Errors Found
- NanoLogix Appoints Global Auto Industry Executive as SVP
- CryoCath named to Deloitte's Technology Fast 500
- Is Your Cat Tight-Lipped When it Comes to His Health? A New Study Finds it's Time to Get Him to Open Wide!
- TMNG will review stock options, delay quarterly filing